US Stock MarketDetailed Quotes

MRK Merck & Co

Watchlist
  • 110.245
  • +0.555+0.51%
Trading Oct 15 09:30 ET
279.45BMarket Cap20.42P/E (TTM)

Merck & Co Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Merck & Co Q3 2024 Estimates Date

Currency：USDOct 31, 2024

Estimate YoY
Revenue
16.49B
+3.29%
EPS
1.47
-20.89%
Analyst Rating
Strong Buy

Oct 15, 2024

Merck & Co Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 16 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
Feb 4, 20252024/Q4-- / 15.642B--
Oct 31, 20242024/Q3-- / 16.487B--
Jul 30, 20242024/Q216.112B / 15.844B--
Apr 25, 20242024/Q115.775B / 15.204B--
Feb 1, 20242023/Q414.630B / 14.480B--
DatePeriodRevenue/EstimateEarnings Call
Feb 4, 20252024/Q4-- / 15.642B--
Oct 31, 20242024/Q3-- / 16.487B--
Jul 30, 20242024/Q216.112B / 15.844B--
Apr 25, 20242024/Q115.775B / 15.204B--
Feb 1, 20242023/Q414.630B / 14.480B--

Unlock Free Earnings Estimates

Merck & Co Earnings Reports

  • Merck & Co | 10-Q: Q2 2024 Earnings Report

    Aug 5 16:07 ET

  • Merck & Co | 10-Q: Q1 2024 Earnings Report

    May 3 16:12 ET

  • Merck & Co | 10-K/A: Annual report (Amendment)

    Apr 11 16:11 ET

  • Merck & Co | 10-K: FY2023 Annual Report

    Feb 26 22:17 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Oct 15, 2024

    Strong Buy

    • Buy

      90.00%

    • Hold

      10.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data

    Concept ESG Investing
    ESG Investing
    Intraday+0.17%
    Infectious Disease
    Infectious Disease
    Intraday0.00%
    Cancer Research
    Cancer Research
    Intraday-0.08%